General Information of the Compound
Compound ID
CP0510199
Compound Name
[(2R,3S)-3-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-acetylpyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-3-[3-[8-(2-phenoxyphenyl)octyl]imidazol-4-yl]propanoyl]amino]-3-hydroxypropanoyl]amino]-4-amino-4-oxobutan-2-yl] dihydrogen phosphate
    Show/Hide
Structure
Formula
C46H67N8O12P
Molecular Weight
955.06
Canonical SMILES
CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(C)=O)C(=O)N[C@@H](Cc1cncn1CCCCCCCCc1ccccc1Oc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)OP(O)(O)=O)C(N)=O
    Show/Hide
InChI
InChI=1S/C46H67N8O12P/c1-30(2)25-36(50-46(61)39-21-16-24-54(39)32(4)56)43(58)49-37(44(59)51-38(28-55)45(60)52-41(42(47)57)31(3)66-67(62,63)64)26-34-27-48-29-53(34)23-15-8-6-5-7-10-17-33-18-13-14-22-40(33)65-35-19-11-9-12-20-35/h9,11-14,18-20,22,27,29-31,36-39,41,55H,5-8,10,15-17,21,23-26,28H2,1-4H3,(H2,47,57)(H,49,58)(H,50,61)(H,51,59)(H,52,60)(H2,62,63,64)/t31-,36+,37+,38+,39+,41+/m1/s1
    Show/Hide
InChIKey
GXROUISBNDMFKO-WTZADEQLSA-N
Physicochemical Property
logP
2.7728
Rotatable Bonds
28
Heavy Atom Count
67
Polar Areas
293.84
Hydrogen Bond Donor Count
8
Hydrogen Bond Acceptor Count
12
Complexity
67

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 134157971
ChEMBL ID
CHEMBL3985321
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01252, Serine/threonine-protein kinase PLK1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
IC50 = 52 nM
   TI
   LI
   LO
   TS